Moore Capital Management LP acquired a new stake in shares of InterCure Ltd. (NASDAQ:INCR – Free Report) in the fourth quarter, Holdings Channel.com reports. The institutional investor acquired 97,273 shares of the company’s stock, valued at approximately $156,000.
Separately, Jane Street Group LLC purchased a new position in InterCure during the third quarter worth about $49,000. 8.34% of the stock is currently owned by institutional investors and hedge funds.
InterCure Stock Up 0.7%
InterCure stock opened at $1.53 on Wednesday. InterCure Ltd. has a fifty-two week low of $1.17 and a fifty-two week high of $3.39. The firm’s 50-day simple moving average is $1.45 and its 200 day simple moving average is $1.53. The company has a debt-to-equity ratio of 0.15, a quick ratio of 1.15 and a current ratio of 1.78.
InterCure Profile
InterCure Ltd., together with its subsidiaries, engages in the research, cultivation, production, and distribution of pharmaceutical-grade cannabis and cannabis-based products for medical use in Israel and internationally. The company offers dried cannabis inflorescences and cannabis extract mixed with oil.
Featured Articles
- Five stocks we like better than InterCure
- How to Effectively Use the MarketBeat Ratings Screener
- NVIDIA Stock Surges on Bullish News: How High Could It Climb?
- What is a support level?
- Why Boeing May Be Ready to Take Off After Latest Developments
- EV Stocks and How to Profit from Them
- eBay Nears Big Breakout: Time to Buy the Under-the-Radar Winner?
Want to see what other hedge funds are holding INCR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for InterCure Ltd. (NASDAQ:INCR – Free Report).
Receive News & Ratings for InterCure Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for InterCure and related companies with MarketBeat.com's FREE daily email newsletter.